Publication date: Available online 6 August 2020Source: Journal of Allergy and Clinical ImmunologyAuthor(s): Stephanie Lovinsky-Desir, Deepti R. Deshpande, Aliva De, Laurie Murray, Jeanette A. Stingone, Angela Chan, Neha Patel, Nooralam Rai, Emily DiMango, Joshua Milner, Meyer Kattan
Thu Aug 06, 2020 20:02
Publication date: Available online 6 August 2020Source: Journal of Allergy and Clinical ImmunologyAuthor(s): Michael Kracht, Ulf Müller-Ladner, M. Lienhard Schmitz
Thu Aug 06, 2020 20:02
Publication date: Available online 6 August 2020Source: Journal of Allergy and Clinical ImmunologyAuthor(s): Craig W. Freyer, David L. Porter
Thu Aug 06, 2020 20:02
Publication date: Available online 5 August 2020Source: Journal of Allergy and Clinical ImmunologyAuthor(s): Rishi R. Goel, Shuichiro Nakabo, Brian L.P. Dizon, Amanda Urban, Meryl Waldman, Lillian Howard, Dirk Darnell, Munir Buhaya, Carmelo Carmona-Rivera, Sarfaraz Hasni, Mariana J. Kaplan, Alexandra F. Freeman, Sarthak Gupta
Thu Aug 06, 2020 20:02
Publication date: August 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 2Author(s): Marc E. Rothenberg, Jean Bousquet
Thu Aug 06, 2020 20:02
Publication date: August 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 2Author(s): Zuhair K. Ballas, Associate Editors of the JACI
Thu Aug 06, 2020 20:02
Publication date: August 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 2Author(s):
Thu Aug 06, 2020 20:02
Publication date: August 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 2Author(s): Caroline Y. Kuo, Donald B. Kohn
Thu Aug 06, 2020 20:02
Publication date: August 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 2Author(s):
Thu Aug 06, 2020 20:02
Publication date: August 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 2Author(s):
Thu Aug 06, 2020 20:02
Publication date: August 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 2Author(s):
Thu Aug 06, 2020 20:02
Publication date: August 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 2Author(s):
Thu Aug 06, 2020 20:02
Publication date: August 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 2Author(s):
Thu Aug 06, 2020 20:02
Publication date: August 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 2Author(s):
Thu Aug 06, 2020 20:02
Publication date: August 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 2Author(s):
Thu Aug 06, 2020 20:02
Publication date: August 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 2Author(s):
Thu Aug 06, 2020 20:02
Publication date: August 2020Source: Journal of Allergy and Clinical Immunology, Volume 146, Issue 2Author(s):
Thu Aug 06, 2020 20:02
Atopic dermatitis (AD) is a chronic inflammatory skin disease that is complicated by an increased risk for skin and systemic infections. Preventive therapy for AD is based on skin barrier improvement and anti-inflammatory treatments, whereas overt skin and systemic infections require antibiotics or anti-viral treatments. This review updates the pathophysiology, diagnosis, management, controversy of antibiotic use, and potential treatments of AD infectious complications.
Thu Aug 06, 2020 03:00
As the director of one of the largest evaluation and treatment centers for patients with aspirin-exacerbated respiratory disease (AERD) in the world, I am often asked how we should approach the use of aspirin desensitization followed by high-dose aspirin therapy for our AERD patients in the current age of newly available biologics. I feel strongly that, at least for now, there is a place for both treatment modalities, sometimes even both in the same patient at the same time. In the end it is always...
Thu Aug 06, 2020 03:00
Urban populations experience disproportionately high rates of asthma morbidity, especially among those from Black/African-American and Hispanic descent1, while indoor allergen sensitization has been implicated in poor health outcomes2. The prevalence of rhinitis is also higher in urban compared to rural populations3. Newark has one of the highest rates of childhood asthma in New Jersey with increased associated emergency room visits and hospitalizations1. In our previously uncharacterized urban population,...
Thu Aug 06, 2020 03:00
IL-35 and IL-35-producing regulatory T cells (iTr35) have been reported to inhibit Th2 response in allergic rhinitis (AR). However, its effects on type II innate lymphoid cells (ILC2) are not well characterized.
Thu Aug 06, 2020 03:00
Background Considerable evidence suggests that smell dysfunction is common in Coronavirus Disease 2019 (COVID‐19). Unfortunately, extant data on prevalence and reversibility over time are highly variable, coming mainly from self‐report surveys prone to multiple biases. Thus, validated psychophysical olfactory testing is sorely needed to establish such parameters. Methods One hundred SARS‐CoV‐2 positive cases were administered the 40‐item University of Pennsylvania Smell Identification Test...
Thu Aug 06, 2020 11:44
Publication date: Available online 6 August 2020Source: Annals of Allergy, Asthma & ImmunologyAuthor(s): Purvi Parikh, Niraj C. Patel, Brit Trogen, Eleanor Feldman, J. Allen Meadows
Thu Aug 06, 2020 20:17
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου